U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H11NO2
Molecular Weight 165.1891
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETHENZAMIDE

SMILES

CCOC1=C(C=CC=C1)C(N)=O

InChI

InChIKey=SBNKFTQSBPKMBZ-UHFFFAOYSA-N
InChI=1S/C9H11NO2/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H2,10,11)

HIDE SMILES / InChI

Description

Ethenzamide is an anti-inflammatory agent that was used for the treatment of common cold in Japan (in combinations with other NSAIDs).

Originator

Approval Year

2018
436
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
NARON ACE

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Cutaneous drug reaction case reports: from the world literature.
2003
Variation in particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling.
2005 Dec
Salicylic acid-induced inactivation of creatine kinase in the presence of lactoperoxidase and H2O2.
2005 Jan 15
Effect of particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling on cohesiveness.
2005 May
Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling.
2006 Mar
Dissolution characteristics of cylindrical particles and tablets.
2006 Mar 9
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination.
2009 Jan 15
Photodegradation of pharmaceuticals and personal care products during UV and UV/H2O2 treatments.
2009 Oct
Ethenzamide-gentisic acid-acetic acid (2/1/1).
2010 Apr 10
Development of theophylline floating microballoons using cellulose acetate butyrate and/or Eudragit RL 100 polymers with different permeability characteristics.
2010 Jan
Patents

Patents

JP2003095934A
1
JP2007246450A
3
JP2008189634A
1
JP2009073851A
1
JP2009280518A
1

Sample Use Guides

In Vivo Use Guide
2 pills containing 84 mg of ethenzamide 3 times a day.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
ETHENZAMIDE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
Ethenzamide [WHO-DD]
Common Name English
ETHENZAMIDE [MI]
Common Name English
ETHENZAMIDE [JAN]
Common Name English
O-ETHOXYBENZAMIDE
Common Name English
ETENZAMIDE
Common Name English
NSC-28787
Code English
ethenzamide [INN]
Common Name English
ETHOXYBENZAMIDE
Systematic Name English
ETHENZAMIDE [MART.]
Common Name English
J3.352I
Code English
Classification Tree Code System Code
WHO-ATC N02BA77
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
NCI_THESAURUS C257
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-VATC QN02BA57
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-VATC QN02BA07
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-ATC N02BA07
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
WHO-ATC N02BA57
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
213-346-4
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
SMS_ID
100000082616
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
ChEMBL
CHEMBL1483877
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
EVMPD
SUB07274MIG
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
FDA UNII
L929ZCK4BF
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
EPA CompTox
DTXSID4020581
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
CAS
938-73-8
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
DRUG BANK
DB13544
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
MESH
C018935
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
PUBCHEM
3282
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
DRUG CENTRAL
1080
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
WIKIPEDIA
ETHENZAMIDE
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
NCI_THESAURUS
C87323
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
RXCUI
24468
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY RxNorm
INN
903
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
MERCK INDEX
m5056
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY Merck Index
NSC
28787
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
DAILYMED
L929ZCK4BF
Created by admin on Sat Dec 16 04:51:05 GMT 2023 , Edited by admin on Sat Dec 16 04:51:05 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of ETHENZAMIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966